President Trump has announced a rise in tariffs on imports, including a 50% tariff on copper products and potential tariffs as high as 200% on pharmaceuticals. A transitional period of one to one and a half years is planned before the pharmaceutical tariffs take effect. The Vanguard S&P 500 ETF is performing well in pre-market trading, up 0.2%, despite concerns over inflation. AES Corporation’s stock rose over 12% amid acquisition interest, and Verona Pharma will be acquired by Merck for $10 billion, increasing its stock by over 20%.
President Trump announced that U.S. imports of copper from any source will be subjected to a 50% tariff, indicating a significant shift in tariff policy.
Pharmaceutical imports may face tariffs as high as 200%, with a timeframe of about a year to a year and a half before the new tariffs are implemented.
The Vanguard S&P 500 ETF, despite inflationary concerns, is trading up 0.2% pre-market, showcasing market resilience amidst new tariff announcements.
AES Corporation's shares surged over 12% pre-market on speculation of acquisitions by Brookfield Asset Management and BlackRock, indicating strong investor interest.
Collection
[
|
...
]